FOR HEALTHCARE PROFESSIONALS

We want to ensure that physicians, researchers, and other healthcare professionals have access to complete, up-to-date, and balanced scientific information regarding gene therapy research and investigational therapies.

As a company, we are dedicated to developing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases.

Please direct any of your medical inquiries to MedInfo@avexis.com

See our Expanding Access to Patients page to learn more about our Managed Access Program. You can also learn more by visiting our Research and Development page.

 

CLINICAL TRIAL INFORMATION

ClinicalTrials.gov

Clinicaltrials.gov is a database of privately and publicly funded clinical studies conducted around the world.

StudySMAnow.com

Learn about AveXis-sponsored research studies for spinal muscular atrophy (SMA).

MANAGED ACCESS PROGRAM

Patients with serious or life-threatening diseases or conditions sometimes seek medical products that are not yet approved or available in their country. AveXis’ “Managed Access” addresses this need by making certain investigational or unapproved treatments available to eligible patients. Click here to learn more

REPORT ADVERSE EVENTS OR PRODUCT COMPLAINTS

To report Adverse Events or Product Quality Complaints, please call AveXis Medical Information at +351 30 880 0322.